M1229 – Patient, who has a reactive hcv antibody test, and has a follow up hcv viral test that detected hcv viremia, is referred within 1 month of the reactive hcv antibody test to a clinician who treats hcv infection
HCPCS Level II code · M codes: Medical Services and Quality Measures
HCPCS codeM1229
- Long description
- Patient, who has a reactive hcv antibody test, and has a follow up hcv viral test that detected hcv viremia, is referred within 1 month of the reactive hcv antibody test to a clinician who treats hcv infection
- Short description
- Pt w/ +hcv +vir ref win 1 mo
- Pricing indicator
00Not separately priced by Part B (bundled, not covered or Part A only)- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
Z2Undefined codes- Added
- January 1, 2024
- Last change
- January 1, 2024 – No change
Frequently asked questions
What is HCPCS code M1229?
M1229 is a HCPCS Level II code for patient, who has a reactive hcv antibody test, and has a follow up hcv viral test that detected hcv viremia, is referred within 1 month of the reactive hcv antibody test to a clinician who treats hcv infection.
Does Medicare cover M1229?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby M codes
- M1221 – Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist or artificial intelligence (ai) interpretation documented and reviewed; without evidence of retinopathy
- M1222 – Glaucoma plan of care not documented, reason not otherwise specified
- M1223 – Glaucoma plan of care documented
- M1224 – Intraocular pressure (iop) reduced by a value less than 20% from the pre-intervention level
- M1225 – Intraocular pressure (iop) reduced by a value of greater than or equal to 20% from the pre-intervention level
- M1226 – Iop measurement not documented, reason not otherwise specified
- M1227 – Evidence-based therapy was prescribed
- M1228 – Patient, who has a reactive hcv antibody test, and has a follow up hcv viral test that detected hcv viremia, has hcv treatment initiated within 3 months of the reactive hcv antibody test
- M1230 – Patient has a reactive hcv antibody test and does not have a follow up hcv viral test, or patient has a reactive hcv antibody test and has a follow up hcv viral test that detects hcv viremia and is not referred to a clinician who treats hcv infection within 1 month and does not have hcv treatment initiated within 3 months of the reactive hcv antibody test, reason not given
- M1231 – Patient receives hcv antibody test with nonreactive result
- M1232 – Patient receives hcv antibody test with reactive result
- M1233 – Patient does not receive hcv antibody test or patient does receive hcv antibody test but results not documented, reason not given
- M1234 – Patient has a reactive hcv antibody test, and has a follow up hcv viral test that does not detect hcv viremia
- M1235 – Documentation or patient report of hcv antibody test or hcv rna test which occurred prior to the performance period
- M1236 – Baseline mrs > 2
- M1237 – Patient reason for not screening for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety (e.g., patient declined or other patient reasons)
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.